TCI Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,707
Closed -$3K 1892
2023
Q1
$3K Buy
1,707
+1,207
+241% +$3.44K ﹤0.01% 1850
2022
Q4
$1.57K Sell
500
-828
-62% -$3.21K ﹤0.01% 2025
2022
Q3
$7K Hold
1,328
﹤0.01% 1288
2022
Q2
$5K Buy
1,328
+828
+166% +$3.58K ﹤0.01% 1532
2022
Q1
$3K Buy
500
+100
+25% +$595 ﹤0.01% 1917
2021
Q4
$3K Sell
400
-200
-33% -$1.74K ﹤0.01% 2034
2021
Q3
$5K Sell
600
-382
-39% -$3.78K ﹤0.01% 1645
2021
Q2
$12K Sell
982
-484
-33% -$5.48K ﹤0.01% 870
2021
Q1
$18K Buy
1,466
+166
+13% +$2.24K 0.01% 613
2020
Q4
$20K Sell
1,300
-1,400
-52% -$16.4K 0.01% 500
2020
Q3
$26K Sell
2,700
-100
-4% -$1.08K 0.01% 404
2020
Q2
$25K Hold
2,800
0.01% 405
2020
Q1
$18K Buy
2,800
+200
+8% +$1.48K 0.01% 466
2019
Q4
$22K Sell
2,600
-1,200
-32% -$11K 0.01% 531
2019
Q3
$34K Buy
3,800
+200
+6% +$2.24K 0.02% 395
2019
Q2
$39K Buy
3,600
+100
+3% +$1.06K 0.02% 359
2019
Q1
$33K Buy
3,500
+100
+3% +$1.02K 0.01% 418
2018
Q4
$39K Buy
3,400
+800
+31% +$9.94K 0.02% 354
2018
Q3
$44K Buy
2,600
+700
+37% +$10.6K 0.02% 366
2018
Q2
$27K Buy
1,900
+700
+58% +$11.6K 0.01% 428
2018
Q1
$23K Buy
1,200
+700
+140% +$15K 0.01% 459
2017
Q4
$8K Buy
+500
New +$7.44K ﹤0.01% 685

Other funds holding SGMO

TCI Wealth Advisors's SGMO Position: Q2 2023 in Review

TCI Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 1,707 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in SGMO in Q4 2017 and held it in 22 quarters. The position peaked at $44K in Q3 2018. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • TCI Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 1,707 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $3K.
  • TCI Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 22 quarters.
  • TCI Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $44K in Q3 2018.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.